There was a significant reduction in apelin levels in patients with both fibrosis (6.5 ± 0.6 pg/ml) and cirrhosis (8.3 ± 1.2 pg/ml) compared to healthy controls (15.4 ± 2.0 pg/ml) (Fig. 1). The gene discussed is APLN; the disease is fibrosis.